HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Austin Poole Selected Research
Austin Poole Research Topics
Disease
3
Renal Cell Carcinoma (Grawitz Tumor)
01/2020 - 06/2015
3
Neoplasms (Cancer)
01/2020 - 01/2015
3
Prostatic Neoplasms (Prostate Cancer)
01/2019 - 09/2017
3
Carcinoma (Carcinomatosis)
01/2017 - 09/2014
1
Mucositis
04/2018
1
Fatigue
04/2018
1
Hand-Foot Syndrome
04/2018
1
Non-Muscle Invasive Bladder Neoplasms
01/2017
1
Urinary Bladder Neoplasms (Bladder Cancer)
01/2017
1
Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
01/2017
1
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2017
1
Hypothyroidism
06/2015
1
Neoplasm Metastasis (Metastasis)
04/2015
1
Leukocytosis (Pleocytosis)
04/2015
1
Anemia
04/2015
1
Cytopenia
09/2014
Drug/Important Bio-Agent (IBA)
2
Prednisone (Sone)
FDA Link
Generic
01/2019 - 01/2018
2
Abiraterone Acetate
IBA
01/2019 - 01/2018
2
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
04/2018 - 06/2015
2
Tyrosine Kinase Inhibitors
IBA
04/2018 - 06/2015
2
Cisplatin (Platino)
FDA Link
Generic
04/2015 - 09/2014
1
pazopanib
FDA Link
01/2020
1
Salts
IBA
01/2019
1
Ketoconazole (Nizoral)
FDA Link
Generic
01/2018
1
Androgens
IBA
01/2018
1
Androgen Antagonists (Antiandrogens)
IBA
09/2017
1
enzalutamide
IBA
09/2017
1
Platinum
IBA
01/2017
1
atezolizumab
IBA
01/2017
1
ibrutinib
IBA
01/2017
1
Thyrotropin (Thyroid-Stimulating Hormone)
FDA Link
06/2015
1
Albumins
IBA
04/2015
1
Biomarkers (Surrogate Marker)
IBA
01/2015
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2015
1
Gemcitabine
FDA Link
09/2014
1
Lenalidomide (CC 5013)
FDA Link
09/2014
Therapy/Procedure
4
Therapeutics
01/2018 - 09/2014
3
Castration
01/2019 - 09/2017
2
Immunotherapy
01/2020 - 01/2017
2
Drug Tapering
04/2018 - 06/2015
2
Drug Therapy (Chemotherapy)
01/2017 - 09/2014
1
Radiotherapy
01/2017